Clinical Trials Browser

Phase 2 × Gastroesophageal Junction Adenocarcinoma × Gastrointestinal × Clear all

NCT04656041 2025-11-14

Folfox+Irinotecan+Chemort In Esophageal Cancer

Phase 2 Recruiting

Gastrointestinal

Gastroesophageal Junction Adenocarcinoma